Karthik Sriram | Parabilis Medicines – Strategic Finance and the Helicon™ Platform Shaping the Future of Peptide Therapeutics

In this episode of Executive Insights for Life Sciences Innovators, we speak with Karthik Sriram, Vice President of Financial Planning & Analysis at Parabilis Medicines, a biopharmaceutical company developing next-generation peptide therapeutics through its innovative Helicon™ platform.Karthik discusses how Parabilis is applying platform science and strategic financial planning to advance medicines designed to deliver extraordinary outcomes for patients. He shares insights from his career journey, transitioning from biomedical engineering into corporate strategy and biotech finance, and highlights how FP&A plays a central role in aligning scientific priorities with operational execution.We explore the company’s vision for the Helicon™ platform, the opportunities and challenges of scaling a clinical-stage organization, and the broader trends shaping the future of peptide therapeutics and biotech company-building.This episode was streamed live on YouTube on December 8, 2025.Learn more at ⁠genecoda.com⁠.